434.22 3.74 (0.87%)
788.1K XNYS Volume
XNYS 20 Mar, 2025 3:48 PM (EDT)
| Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|
| Ronald W. Penczek | CAO & Controller | Sale of securities on an exchange or to another person at price $ 415.13 per share. | 10 Mar 2025 | 443 | 1,847 (0%) | 0% | 415.1 | 183,903 | Common Stock |
| Gail Koziara Boudreaux | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Mar 2025 | 15,587 | 142,520 (0%) | 0% | 0 | Common Stock | |
| Gail Koziara Boudreaux | Director, President and CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 395.50 per share. | 03 Mar 2025 | 10,396 | 116,313 (0%) | 0% | 395.5 | 4,111,618 | Common Stock |
| Gail Koziara Boudreaux | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Mar 2025 | 10,620 | 126,933 (0%) | 0% | 0 | Common Stock | |
| Gail Koziara Boudreaux | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Mar 2025 | 40,429 | 40,429 | - | - | Employee Stock Option (Right to Buy) | |
| Peter D. Haytaian | EVP & Pres Carelon & CarelonRx | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Mar 2025 | 3,035 | 21,791 (0%) | 0% | 0 | Common Stock | |
| Peter D. Haytaian | EVP & Pres Carelon & CarelonRx | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Mar 2025 | 4,213 | 26,004 (0%) | 0% | 0 | Common Stock | |
| Peter D. Haytaian | EVP & Pres Carelon & CarelonRx | Payment of exercise price or tax liability using portion of securities received from the company at price $ 395.50 per share. | 03 Mar 2025 | 2,281 | 18,756 (0%) | 0% | 395.5 | 902,136 | Common Stock |
| Peter D. Haytaian | EVP & Pres Carelon & CarelonRx | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Mar 2025 | 11,549 | 11,549 | - | - | Employee Stock Option (Right to Buy) | |
| Mark B. Kaye | EVP & CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Mar 2025 | 13,713 | 13,713 | - | - | Employee Stock Option (Right to Buy) | |
| Mark B. Kaye | EVP & CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Mar 2025 | 3,604 | 23,565 (0%) | 0% | 0 | Common Stock | |
| Mark B. Kaye | EVP & CFO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 395.50 per share. | 03 Mar 2025 | 270 | 19,961 (0%) | 0% | 395.5 | 106,785 | Common Stock |
| Ronald W. Penczek | CAO & Controller | Payment of exercise price or tax liability using portion of securities received from the company at price $ 395.50 per share. | 03 Mar 2025 | 198 | 1,584 (0%) | 0% | 395.5 | 78,309 | Common Stock |
| Ronald W. Penczek | CAO & Controller | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Mar 2025 | 421 | 2,290 (0%) | 0% | 0 | Common Stock | |
| Ronald W. Penczek | CAO & Controller | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Mar 2025 | 1,081 | 1,081 | - | - | Employee Stock Option (Right to Buy) | |
| Ronald W. Penczek | CAO & Controller | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Mar 2025 | 285 | 1,869 (0%) | 0% | 0 | Common Stock | |
| Ratnakar V. Lavu | EVP, Chief Digital & Info Off | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Mar 2025 | 8,902 | 8,902 | - | - | Employee Stock Option (Right to Buy) | |
| Ratnakar V. Lavu | EVP, Chief Digital & Info Off | Payment of exercise price or tax liability using portion of securities received from the company at price $ 395.50 per share. | 03 Mar 2025 | 312 | 2,444 (0%) | 0% | 395.5 | 123,396 | Common Stock |
| Ratnakar V. Lavu | EVP, Chief Digital & Info Off | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Mar 2025 | 2,339 | 4,783 (0%) | 0% | 0 | Common Stock | |
| Felicia F Norwood | EVP & President,Gov Health Ben | Payment of exercise price or tax liability using portion of securities received from the company at price $ 395.50 per share. | 03 Mar 2025 | 2,613 | 24,691 (0%) | 0% | 395.5 | 1,033,442 | Common Stock |
| Felicia F Norwood | EVP & President,Gov Health Ben | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Mar 2025 | 3,035 | 27,726 (0%) | 0% | 0 | Common Stock | |
| Felicia F Norwood | EVP & President,Gov Health Ben | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Mar 2025 | 4,213 | 31,939 (0%) | 0% | 0 | Common Stock | |
| Felicia F Norwood | EVP & President,Gov Health Ben | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Mar 2025 | 11,549 | 11,549 | - | - | Employee Stock Option (Right to Buy) | |
| Charles Morgan Kendrick | EVP & President, Commercial | Payment of exercise price or tax liability using portion of securities received from the company at price $ 395.50 per share. | 03 Mar 2025 | 2,221 | 7,089 (0%) | 0% | 395.5 | 878,406 | Common Stock |
| Charles Morgan Kendrick | EVP & President, Commercial | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Mar 2025 | 2,845 | 9,934 (0%) | 0% | 0 | Common Stock | |
| Charles Morgan Kendrick | EVP & President, Commercial | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Mar 2025 | 3,686 | 13,620 (0%) | 0% | 0 | Common Stock | |
| Charles Morgan Kendrick | EVP & President, Commercial | Sale of securities on an exchange or to another person at price $ 396.30 per share. | 03 Mar 2025 | 3,504 | 10,116 (0%) | 0% | 396.3 | 1,388,635 | Common Stock |
| Charles Morgan Kendrick | EVP & President, Commercial | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Mar 2025 | 10,828 | 10,828 | - | - | Employee Stock Option (Right to Buy) | |
| Peter D. Haytaian | EVP & Pres Carelon & CarelonRx | Payment of exercise price or tax liability using portion of securities received from the company at price $ 414.01 per share. | 01 Nov 2024 | 1,649 | 17,238 (0%) | 0% | 414.0 | 682,702 | Common Stock |
| Peter D. Haytaian | EVP & Pres Carelon & CarelonRx | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Nov 2024 | 3,799 | 21,037 (0%) | 0% | 0 | Common Stock | |
| Charles Morgan Kendrick | EVP & President, Commercial | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Nov 2024 | 1,710 | 9,287 (0%) | 0% | 0 | Common Stock | |
| Charles Morgan Kendrick | EVP & President, Commercial | Payment of exercise price or tax liability using portion of securities received from the company at price $ 414.01 per share. | 01 Nov 2024 | 846 | 7,577 (0%) | 0% | 414.0 | 350,252 | Common Stock |
| Charles Morgan Kendrick | EVP & President, Commercial | Sale of securities on an exchange or to another person at price $ 432.14 per share. | 18 Oct 2024 | 7,417 | 8,423 (0%) | 0% | 432.1 | 3,205,182 | Common Stock |
| Mark B. Kaye | EVP & CFO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 505.16 per share. | 02 Oct 2024 | 2,818 | 20,213 (0%) | 0% | 505.2 | 1,423,541 | Common Stock |
| Ramiro G. Peru | Director | Sale of securities on an exchange or to another person at price $ 531.52 per share. | 05 Aug 2024 | 753 | 8,744 (0%) | 0% | 531.5 | 400,235 | Common Stock |
| Gail Koziara Boudreaux | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 498.50 per share. | 22 Jul 2024 | 1,100 | 159,609 (0%) | 0% | 498.5 | 548,350 | Common Stock |
| Gail Koziara Boudreaux | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 504.27 per share. | 22 Jul 2024 | 2,250 | 126,709 (0%) | 0% | 504.3 | 1,134,608 | Common Stock |
| Gail Koziara Boudreaux | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 503.67 per share. | 22 Jul 2024 | 1,000 | 128,959 (0%) | 0% | 503.7 | 503,670 | Common Stock |
| Gail Koziara Boudreaux | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 502.23 per share. | 22 Jul 2024 | 2,250 | 129,959 (0%) | 0% | 502.2 | 1,130,018 | Common Stock |
| Gail Koziara Boudreaux | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 501.40 per share. | 22 Jul 2024 | 6,621 | 132,209 (0%) | 0% | 501.4 | 3,319,769 | Common Stock |
| Gail Koziara Boudreaux | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 500.36 per share. | 22 Jul 2024 | 20,779 | 138,830 (0%) | 0% | 500.4 | 10,396,980 | Common Stock |
| Robert L. Dixon | Director | Sale of securities on an exchange or to another person at price $ 506.76 per share. | 19 Jul 2024 | 305 | 9,721 (0%) | 0% | 506.8 | 154,562 | Common Stock |
| Deanna Strable-Soethout | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 May 2024 | 388 | 1,045 (0%) | 0% | 0 | Common Stock | |
| Elizabeth E. Tallett | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 May 2024 | 388 | 10,291 (0%) | 0% | 0 | Common Stock | |
| Lewis Hay | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 May 2024 | 388 | 10,906 (0%) | 0% | 0 | Common Stock | |
| Ryan M. Schneider | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 May 2024 | 388 | 5,999 (0%) | 0% | 0 | Common Stock | |
| R. Kerry Clark | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 May 2024 | 388 | 9,039 (0%) | 0% | 0 | Common Stock | |
| Ramiro G. Peru | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 May 2024 | 388 | 9,497 (0%) | 0% | 0 | Common Stock | |
| Robert L. Dixon | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 May 2024 | 388 | 10,026 (0%) | 0% | 0 | Common Stock | |
| Bahija Jallal | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 May 2024 | 388 | 4,187 (0%) | 0% | 0 | Common Stock | |
| Susan Dodson DeVore | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 May 2024 | 388 | 1,701 (0%) | 0% | 0 | Common Stock | |
| Antonio Fabio Neri | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 May 2024 | 388 | 4,324 (0%) | 0% | 0 | Common Stock | |
| Felicia F Norwood | EVP & President,Gov Health Ben | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 23 Apr 2024 | 5,473 | 2,043 | - | - | Employee Stock Option (right to buy) | |
| Felicia F Norwood | EVP & President,Gov Health Ben | Sale of securities on an exchange or to another person at price $ 532.68 per share. | 23 Apr 2024 | 3,434 | 27,304 (0%) | 0% | 532.7 | 1,829,223 | Common Stock |
| Felicia F Norwood | EVP & President,Gov Health Ben | Sale of securities on an exchange or to another person at price $ 532.14 per share. | 23 Apr 2024 | 2,765 | 30,738 (0%) | 0% | 532.1 | 1,471,367 | Common Stock |
| Felicia F Norwood | EVP & President,Gov Health Ben | Exercise or conversion of derivative security received from the company (such as an option) at price $ 238.27 per share. | 23 Apr 2024 | 2,043 | 33,503 (0%) | 0% | 238.3 | 486,786 | Common Stock |
| Felicia F Norwood | EVP & President,Gov Health Ben | Sale of securities on an exchange or to another person at price $ 534.74 per share. | 23 Apr 2024 | 100 | 31,460 (0%) | 0% | 534.7 | 53,474 | Common Stock |
| Felicia F Norwood | EVP & President,Gov Health Ben | Sale of securities on an exchange or to another person at price $ 533.73 per share. | 23 Apr 2024 | 14,011 | 31,560 (0%) | 0% | 533.7 | 7,478,091 | Common Stock |
| Felicia F Norwood | EVP & President,Gov Health Ben | Exercise or conversion of derivative security received from the company (such as an option) at price $ 238.27 per share. | 23 Apr 2024 | 5,473 | 45,571 (0%) | 0% | 238.3 | 1,304,052 | Common Stock |
| Felicia F Norwood | EVP & President,Gov Health Ben | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 23 Apr 2024 | 2,043 | 0 | - | - | Employee Stock Option (right to buy) | |
| Charles Morgan Kendrick | EVP & President, Commercial | Sale of securities on an exchange or to another person at price $ 500.46 per share. | 08 Mar 2024 | 2,432 | 15,840 (0%) | 0% | 500.5 | 1,217,119 | Common Stock |
| Ronald W. Penczek | CAO & Controller | Sale of securities on an exchange or to another person at price $ 504.58 per share. | 06 Mar 2024 | 916 | 1,764 (0%) | 0% | 504.6 | 462,195 | Common Stock |
| Blair W. Todt | EVP, CLO & CAO | 01 Mar 2024 | 8,312 | 8,312 | - | - | Employee Stock Option (Right to Buy) | ||
| Blair W. Todt | EVP, CLO & CAO | 01 Mar 2024 | 6,537 | 17,156 (0%) | 0% | 0 | Common Stock | ||
| Blair W. Todt | EVP, CLO & CAO | 01 Mar 2024 | 3,650 | 8,465 (0%) | 0% | 499.1 | 1,821,752 | Common Stock | |
| Blair W. Todt | EVP, CLO & CAO | 01 Mar 2024 | 2,154 | 10,619 (0%) | 0% | 0 | Common Stock | ||
| Gail Koziara Boudreaux | Director, President and CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 499.11 per share. | 01 Mar 2024 | 19,256 | 117,777 (0%) | 0% | 499.1 | 9,610,862 | Common Stock |
| Gail Koziara Boudreaux | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2024 | 8,415 | 126,192 (0%) | 0% | 0 | Common Stock | |
| Gail Koziara Boudreaux | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2024 | 34,517 | 160,709 (0%) | 0% | 0 | Common Stock | |
| Gail Koziara Boudreaux | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2024 | 32,480 | 32,480 | - | - | Employee Stock Option (Right to Buy) | |
| Peter Haytaian D. | EVP & Pres Carelon & CarelonRx | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2024 | 9,152 | 24,982 (0%) | 0% | 0 | Common Stock | |
| Peter Haytaian D. | EVP & Pres Carelon & CarelonRx | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2024 | 2,405 | 15,830 (0%) | 0% | 0 | Common Stock | |
| Peter Haytaian D. | EVP & Pres Carelon & CarelonRx | Exercise or conversion of derivative security received from the company (such as an option) at price $ 166.97 per share. | 01 Mar 2024 | 15,000 | 39,982 (0%) | 0% | 167.0 | 2,504,550 | Common Stock |
| Peter Haytaian D. | EVP & Pres Carelon & CarelonRx | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Mar 2024 | 15,000 | 4,908 | - | - | Employee Stock Option (Right to Buy) | |
| Peter Haytaian D. | EVP & Pres Carelon & CarelonRx | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2024 | 9,280 | 9,280 | - | - | Employee Stock Option (Right to Buy) | |
| Peter Haytaian D. | EVP & Pres Carelon & CarelonRx | Sale of securities on an exchange or to another person at price $ 500.18 per share. | 01 Mar 2024 | 15,000 | 18,887 (0%) | 0% | 500.2 | 7,502,700 | Common Stock |
| Peter Haytaian D. | EVP & Pres Carelon & CarelonRx | Sale of securities on an exchange or to another person at price $ 500.18 per share. | 01 Mar 2024 | 1,889 | 33,887 (0%) | 0% | 500.2 | 944,840 | Common Stock |
| Peter Haytaian D. | EVP & Pres Carelon & CarelonRx | Sale of securities on an exchange or to another person at price $ 500.18 per share. | 01 Mar 2024 | 4,206 | 35,776 (0%) | 0% | 500.2 | 2,103,757 | Common Stock |
| Peter Haytaian D. | EVP & Pres Carelon & CarelonRx | Payment of exercise price or tax liability using portion of securities received from the company at price $ 499.11 per share. | 01 Mar 2024 | 4,314 | 13,425 (0%) | 0% | 499.1 | 2,153,161 | Common Stock |
| Mark Kaye B. | EVP & CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2024 | 10,633 | 10,633 | - | - | Employee Stock Option (Right to Buy) | |
| Mark Kaye B. | EVP & CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2024 | 2,755 | 23,031 (0%) | 0% | 0 | Common Stock | |
| Ronald W. Penczek | CAO & Controller | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2024 | 867 | 867 | - | - | Employee Stock Option (Right to Buy) | |
| Ronald W. Penczek | CAO & Controller | Payment of exercise price or tax liability using portion of securities received from the company at price $ 499.11 per share. | 01 Mar 2024 | 383 | 1,408 (0%) | 0% | 499.1 | 191,159 | Common Stock |
| Ronald W. Penczek | CAO & Controller | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2024 | 226 | 1,634 (0%) | 0% | 0 | Common Stock | |
| Ronald W. Penczek | CAO & Controller | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2024 | 1,046 | 2,680 (0%) | 0% | 0 | Common Stock | |
| Felicia F Norwood | EVP & President,Gov Health Ben | Payment of exercise price or tax liability using portion of securities received from the company at price $ 499.11 per share. | 01 Mar 2024 | 4,902 | 28,541 (0%) | 0% | 499.1 | 2,446,637 | Common Stock |
| Felicia F Norwood | EVP & President,Gov Health Ben | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2024 | 9,280 | 9,280 | - | - | Employee Stock Option (Right to Buy) | |
| Felicia F Norwood | EVP & President,Gov Health Ben | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2024 | 9,152 | 40,098 (0%) | 0% | 0 | Common Stock | |
| Felicia F Norwood | EVP & President,Gov Health Ben | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2024 | 2,405 | 30,946 (0%) | 0% | 0 | Common Stock | |
| Charles Morgan Kendrick | EVP & President, Commercial | Payment of exercise price or tax liability using portion of securities received from the company at price $ 499.11 per share. | 01 Mar 2024 | 1,484 | 13,764 (0%) | 0% | 499.1 | 740,679 | Common Stock |
| Charles Morgan Kendrick | EVP & President, Commercial | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2024 | 2,354 | 18,272 (0%) | 0% | 0 | Common Stock | |
| Charles Morgan Kendrick | EVP & President, Commercial | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2024 | 2,154 | 15,918 (0%) | 0% | 0 | Common Stock | |
| Charles Morgan Kendrick | EVP & President, Commercial | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2024 | 8,312 | 8,312 | - | - | Employee Stock Option (Right to Buy) | |
| Ratnakar V. Lavu | EVP & Chief Digital Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2024 | 1,754 | 1,754 (0%) | 0% | 0 | Common Stock | |
| Ratnakar V. Lavu | EVP & Chief Digital Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2024 | 1,002 | 2,756 (0%) | 0% | 0 | Common Stock | |
| Ratnakar V. Lavu | EVP & Chief Digital Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2024 | 6,765 | 6,765 | - | - | Employee Stock Option (Right to Buy) | |
| G. Peru Ramiro | Director | Sale of securities on an exchange or to another person at price $ 500.00 per share. | 07 Feb 2024 | 753 | 9,109 (0%) | 0% | 500 | 376,500 | Common Stock |
| Blair W. Todt | EVP, CLO & CAO | 03 Jan 2024 | 397 | 12,115 (0%) | 0% | 480.5 | 190,755 | Common Stock | |
| Todt Blair W. | EVP, CLO & CAO | 14 Dec 2023 | 5,492 | 12,512 (0%) | 0% | 484.0 | 2,658,238 | Common Stock | |
| Todt Blair W. | EVP, CLO & CAO | 14 Dec 2023 | 5,492 | 18,004 (0%) | 0% | 311.5 | 1,710,648 | Common Stock | |
| Todt Blair W. | EVP, CLO & CAO | 14 Dec 2023 | 5,492 | 2,746 | - | - | Employee Stock Option (Right to Buy) | ||
| Blair W. Todt | EVP, CLO & CAO | 01 Dec 2023 | 116 | 12,512 (0%) | 0% | 483.1 | 56,042 | Common Stock | |
| Blair W. Todt | EVP, CLO & CAO | 01 Dec 2023 | 398 | 15,631 (0%) | 0% | 371.6 | 147,881 | Common Stock | |
| Blair W. Todt | EVP, CLO & CAO | 01 Dec 2023 | 1,127 | 16,029 (0%) | 0% | 483.1 | 544,476 | Common Stock | |
| Ronald W. Penczek | CAO & Controller | Sale of securities on an exchange or to another person at price $ 475.17 per share. | 30 Nov 2023 | 1,055 | 1,787 (0%) | 0% | 475.2 | 501,304 | Common Stock |
| Peter Haytaian | EVP & Pres Carelon & CarelonRx | Payment of exercise price or tax liability using portion of securities received from the company at price $ 446.66 per share. | 01 Nov 2023 | 154 | 17,739 (0%) | 0% | 446.7 | 68,786 | Common Stock |
| Charles Morgan Kendrick | EVP & President, Commercial | Payment of exercise price or tax liability using portion of securities received from the company at price $ 446.66 per share. | 01 Nov 2023 | 79 | 15,248 (0%) | 0% | 446.7 | 35,286 | Common Stock |
| Ronald W. Penczek | CAO & Controller | Sale of securities on an exchange or to another person at price $ 454.34 per share. | 24 Oct 2023 | 64 | 2,842 (0%) | 0% | 454.3 | 29,078 | Common Stock |
| Mark Kaye | EVP & CFO Designate | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Oct 2023 | 18,174 | 18,174 (0%) | 0% | 0 | Common Stock | |
| Mark Kaye | EVP & CFO Designate | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Oct 2023 | 8,076 | 8,076 | - | - | Employee Stock Option (Right to Buy) | |
| Mark Kaye | EVP & CFO Designate | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Oct 2023 | 2,102 | 20,276 (0%) | 0% | 0 | Common Stock | |
| Robert L. Dixon | Director | Sale of securities on an exchange or to another person at price $ 476.71 per share. | 21 Jul 2023 | 310 | 9,638 (0%) | 0% | 476.7 | 147,780 | Common Stock |
| Deanna Strable-Soethout | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 May 2023 | 457 | 657 (0%) | 0% | 0 | Common Stock | |
| Elizabeth E. Tallett | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 May 2023 | 457 | 9,903 (0%) | 0% | 0 | Common Stock | |
| Lewis Hay | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 May 2023 | 457 | 10,518 (0%) | 0% | 0 | Common Stock | |
| Ryan M. Schneider | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 May 2023 | 457 | 5,611 (0%) | 0% | 0 | Common Stock | |
| R. Kerry Clark | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 May 2023 | 457 | 8,651 (0%) | 0% | 0 | Common Stock | |
| Ramiro G. Peru | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 May 2023 | 457 | 9,862 (0%) | 0% | 0 | Common Stock | |
| Robert L. Dixon | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 May 2023 | 457 | 9,948 (0%) | 0% | 0 | Common Stock | |
| Bahija Jallal | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 May 2023 | 457 | 3,799 (0%) | 0% | 0 | Common Stock | |
| Susan Dodson DeVore | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 May 2023 | 457 | 1,313 (0%) | 0% | 0 | Common Stock | |
| Antonio Fabio Neri | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 May 2023 | 457 | 3,936 (0%) | 0% | 0 | Common Stock | |
| Gloria M. McCarthy | EVP & Chief Administrative Off | Sale of securities on an exchange or to another person at price $ 440.78 per share. | 24 Mar 2023 | 600 | 65,933 (0%) | 0% | 440.8 | 264,468 | Common Stock |
| Gloria M. McCarthy | EVP & Chief Administrative Off | Sale of securities on an exchange or to another person at price $ 446.06 per share. | 24 Mar 2023 | 3,625 | 51,435 (0%) | 0% | 446.1 | 1,616,968 | Common Stock |
| Gloria M. McCarthy | EVP & Chief Administrative Off | Sale of securities on an exchange or to another person at price $ 445.30 per share. | 24 Mar 2023 | 5,573 | 55,060 (0%) | 0% | 445.3 | 2,481,657 | Common Stock |
| Gloria M. McCarthy | EVP & Chief Administrative Off | Sale of securities on an exchange or to another person at price $ 444.33 per share. | 24 Mar 2023 | 3,000 | 60,633 (0%) | 0% | 444.3 | 1,332,990 | Common Stock |
| Gloria M. McCarthy | EVP & Chief Administrative Off | Sale of securities on an exchange or to another person at price $ 443.27 per share. | 24 Mar 2023 | 1,800 | 63,633 (0%) | 0% | 443.3 | 797,886 | Common Stock |
| Gloria M. McCarthy | EVP & Chief Administrative Off | Sale of securities on an exchange or to another person at price $ 442.02 per share. | 24 Mar 2023 | 500 | 65,433 (0%) | 0% | 442.0 | 221,010 | Common Stock |
| Charles Morgan Kendrick | EVP & President, Commercial | Sale of securities on an exchange or to another person at price $ 462.22 per share. | 09 Mar 2023 | 2,314 | 15,327 (0%) | 0% | 462.2 | 1,069,577 | Common Stock |
| Blair W. Todt | EVP and Chief Legal Officer | 01 Mar 2023 | 2,133 | 10,044 (0%) | 0% | 0 | Common Stock | ||
| Blair W. Todt | EVP and Chief Legal Officer | 01 Mar 2023 | 372 | 7,911 (0%) | 0% | 469.0 | 174,479 | Common Stock | |
| Blair W. Todt | EVP and Chief Legal Officer | 01 Mar 2023 | 2,584 | 12,628 (0%) | 0% | 0 | Common Stock | ||
| Blair W. Todt | EVP and Chief Legal Officer | 01 Mar 2023 | 8,195 | 8,195 | - | - | Employee Stock Option (Right to Buy) | ||
| Gail Koziara Boudreaux | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2023 | 32,380 | 32,380 | - | - | Employee Stock Option (Right to Buy) | |
| Gail Koziara Boudreaux | Director, President and CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 469.03 per share. | 01 Mar 2023 | 2,471 | 109,180 (0%) | 0% | 469.0 | 1,158,973 | Common Stock |
| Gail Koziara Boudreaux | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2023 | 8,422 | 117,602 (0%) | 0% | 0 | Common Stock | |
| Gail Koziara Boudreaux | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2023 | 35,875 | 153,477 (0%) | 0% | 0 | Common Stock | |
| Gail Koziara Boudreaux | Director, President and CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 468.78 per share. | 01 Mar 2023 | 17,614 | 135,863 (0%) | 0% | 468.8 | 8,257,091 | Common Stock |
| John E. Gallina | EVP & Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 468.78 per share. | 01 Mar 2023 | 4,650 | 63,725 (0%) | 0% | 468.8 | 2,179,827 | Common Stock |
| John E. Gallina | EVP & Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2023 | 9,716 | 68,375 (0%) | 0% | 0 | Common Stock | |
| John E. Gallina | EVP & Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2023 | 3,065 | 58,659 (0%) | 0% | 0 | Common Stock | |
| John E. Gallina | EVP & Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 469.03 per share. | 01 Mar 2023 | 587 | 55,594 (0%) | 0% | 469.0 | 275,321 | Common Stock |
| John E. Gallina | EVP & Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2023 | 11,782 | 11,782 | - | - | Employee Stock Option (Right to Buy) | |
| Gloria M. McCarthy | EVP & Chief Administrative Off | Payment of exercise price or tax liability using portion of securities received from the company at price $ 469.03 per share. | 01 Mar 2023 | 617 | 60,114 (0%) | 0% | 469.0 | 289,392 | Common Stock |
| Gloria M. McCarthy | EVP & Chief Administrative Off | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2023 | 8,195 | 8,195 | - | - | Employee Stock Option (Right to Buy) | |
| Gloria M. McCarthy | EVP & Chief Administrative Off | Payment of exercise price or tax liability using portion of securities received from the company at price $ 468.78 per share. | 01 Mar 2023 | 5,430 | 66,533 (0%) | 0% | 468.8 | 2,545,475 | Common Stock |
| Gloria M. McCarthy | EVP & Chief Administrative Off | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2023 | 9,716 | 71,963 (0%) | 0% | 0 | Common Stock | |
| Gloria M. McCarthy | EVP & Chief Administrative Off | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2023 | 2,133 | 62,247 (0%) | 0% | 0 | Common Stock | |
| Peter Haytaian | EVP & Pres Carelon & CarelonRx | Payment of exercise price or tax liability using portion of securities received from the company at price $ 469.03 per share. | 01 Mar 2023 | 607 | 11,354 (0%) | 0% | 469.0 | 284,701 | Common Stock |
| Peter Haytaian | EVP & Pres Carelon & CarelonRx | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2023 | 8,812 | 8,812 | - | - | Employee Stock Option (Right to Buy) | |
| Peter Haytaian | EVP & Pres Carelon & CarelonRx | Payment of exercise price or tax liability using portion of securities received from the company at price $ 468.78 per share. | 01 Mar 2023 | 5,469 | 17,893 (0%) | 0% | 468.8 | 2,563,758 | Common Stock |
| Peter Haytaian | EVP & Pres Carelon & CarelonRx | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2023 | 9,716 | 23,362 (0%) | 0% | 0 | Common Stock | |
| Peter Haytaian | EVP & Pres Carelon & CarelonRx | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2023 | 2,292 | 13,646 (0%) | 0% | 0 | Common Stock | |
| Ronald W. Penczek | CAO & Controller | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2023 | 1,195 | 3,262 (0%) | 0% | 0 | Common Stock | |
| Ronald W. Penczek | CAO & Controller | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2023 | 214 | 2,067 (0%) | 0% | 0 | Common Stock | |
| Ronald W. Penczek | CAO & Controller | Payment of exercise price or tax liability using portion of securities received from the company at price $ 469.03 per share. | 01 Mar 2023 | 64 | 1,853 (0%) | 0% | 469.0 | 30,018 | Common Stock |
| Ronald W. Penczek | CAO & Controller | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2023 | 819 | 819 | - | - | Employee Stock Option (Right to Buy) | |
| Ronald W. Penczek | CAO & Controller | Payment of exercise price or tax liability using portion of securities received from the company at price $ 468.78 per share. | 01 Mar 2023 | 380 | 2,882 (0%) | 0% | 468.8 | 178,136 | Common Stock |
| Felicia F Norwood | EVP & President, GBD | Payment of exercise price or tax liability using portion of securities received from the company at price $ 468.78 per share. | 01 Mar 2023 | 4,754 | 33,443 (0%) | 0% | 468.8 | 2,228,580 | Common Stock |
| Felicia F Norwood | EVP & President, GBD | Payment of exercise price or tax liability using portion of securities received from the company at price $ 469.03 per share. | 01 Mar 2023 | 495 | 26,189 (0%) | 0% | 469.0 | 232,170 | Common Stock |
| Felicia F Norwood | EVP & President, GBD | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2023 | 2,292 | 28,481 (0%) | 0% | 0 | Common Stock | |
| Felicia F Norwood | EVP & President, GBD | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2023 | 9,716 | 38,197 (0%) | 0% | 0 | Common Stock | |
| Felicia F Norwood | EVP & President, GBD | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2023 | 8,812 | 8,812 | - | - | Employee Stock Option (Right to Buy) | |
| Charles Morgan Kendrick | EVP & President, Commercial | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2023 | 2,542 | 18,725 (0%) | 0% | 0 | Common Stock | |
| Charles Morgan Kendrick | EVP & President, Commercial | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2023 | 2,026 | 16,183 (0%) | 0% | 0 | Common Stock | |
| Charles Morgan Kendrick | EVP & President, Commercial | Payment of exercise price or tax liability using portion of securities received from the company at price $ 469.03 per share. | 01 Mar 2023 | 293 | 14,157 (0%) | 0% | 469.0 | 137,426 | Common Stock |
| Charles Morgan Kendrick | EVP & President, Commercial | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2023 | 7,786 | 7,786 | - | - | Employee Stock Option (Right to Buy) | |
| Charles Morgan Kendrick | EVP & President, Commercial | Payment of exercise price or tax liability using portion of securities received from the company at price $ 468.78 per share. | 01 Mar 2023 | 1,084 | 17,641 (0%) | 0% | 468.8 | 508,158 | Common Stock |
| Blair W. Todt | EVP and Chief Legal Officer | 03 Jan 2023 | 3,983 | 8,283 (0%) | 0% | 0 | Common Stock | ||
| Felicia F Norwood | EVP & President, GBD | Payment of exercise price or tax liability using portion of securities received from the company at price $ 512.97 per share. | 30 Dec 2022 | 1,754 | 26,684 (0%) | 0% | 513.0 | 899,749 | Common Stock |
| Blair W. Todt | EVP and Chief Legal Officer | 01 Dec 2022 | 117 | 4,300 (0%) | 0% | 525.2 | 61,454 | Common Stock | |
| Gail Koziara Boudreaux | Director, President and CEO | Gift of securities by or to the insider at price $ 0.00 per share. | 04 Nov 2022 | 10,000 | 111,415 (0%) | 0% | 0 | Common Stock | |
| Deanna Strable-Soethout | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Nov 2022 | 200 | 200 (0%) | 0% | 0 | Common Stock | |
| Peter Haytaian | EVP & Pres Carelon & IngenioRx | Payment of exercise price or tax liability using portion of securities received from the company at price $ 544.53 per share. | 01 Nov 2022 | 200 | 11,961 (0%) | 0% | 544.5 | 108,906 | Common Stock |
| Charles Morgan Kendrick | EVP & President, Commercial | Payment of exercise price or tax liability using portion of securities received from the company at price $ 544.53 per share. | 01 Nov 2022 | 79 | 14,450 (0%) | 0% | 544.5 | 43,018 | Common Stock |
| Charles Morgan Kendrick | EVP & President, Commercial | Exercise or conversion of derivative security received from the company (such as an option) at price $ 271.27 per share. | 09 Jun 2022 | 2,774 | 19,302 (0%) | 0% | 271.3 | 752,503 | Common Stock |
| Charles Morgan Kendrick | EVP & President, Commercial | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 Jun 2022 | 987 | 1,976 | - | - | Employee Stock Option (Right to Buy) | |
| Charles Morgan Kendrick | EVP & President, Commercial | Sale of securities on an exchange or to another person at price $ 488.64 per share. | 09 Jun 2022 | 2,616 | 16,041 (0%) | 0% | 488.6 | 1,278,282 | Common Stock |
| Charles Morgan Kendrick | EVP & President, Commercial | Sale of securities on an exchange or to another person at price $ 487.45 per share. | 09 Jun 2022 | 2,200 | 18,657 (0%) | 0% | 487.5 | 1,072,390 | Common Stock |
| Charles Morgan Kendrick | EVP & President, Commercial | Exercise or conversion of derivative security received from the company (such as an option) at price $ 311.48 per share. | 09 Jun 2022 | 987 | 20,857 (0%) | 0% | 311.5 | 307,431 | Common Stock |
| Charles Morgan Kendrick | EVP & President, Commercial | Exercise or conversion of derivative security received from the company (such as an option) at price $ 232.04 per share. | 09 Jun 2022 | 568 | 19,870 (0%) | 0% | 232.0 | 131,799 | Common Stock |
| Charles Morgan Kendrick | EVP & President, Commercial | Exercise or conversion of derivative security received from the company (such as an option) at price $ 307.68 per share. | 09 Jun 2022 | 1,999 | 16,528 (0%) | 0% | 307.7 | 615,052 | Common Stock |
| Charles Morgan Kendrick | EVP & President, Commercial | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 Jun 2022 | 568 | 0 | - | - | Employee Stock Option (Right to Buy) | |
| Charles Morgan Kendrick | EVP & President, Commercial | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 Jun 2022 | 2,774 | 1,387 | - | - | Employee Stock Option (Right to Buy) | |
| Charles Morgan Kendrick | EVP & President, Commercial | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 Jun 2022 | 1,999 | 0 | - | - | Employee Stock Option (Right to Buy) | |
| Charles Morgan Kendrick | EVP & President, Commercial | Sale of securities on an exchange or to another person at price $ 491.39 per share. | 09 Jun 2022 | 206 | 14,529 (0%) | 0% | 491.4 | 101,226 | Common Stock |
| Charles Morgan Kendrick | EVP & President, Commercial | Sale of securities on an exchange or to another person at price $ 490.83 per share. | 09 Jun 2022 | 522 | 14,735 (0%) | 0% | 490.8 | 256,213 | Common Stock |
| Charles Morgan Kendrick | EVP & President, Commercial | Sale of securities on an exchange or to another person at price $ 489.49 per share. | 09 Jun 2022 | 784 | 15,257 (0%) | 0% | 489.5 | 383,760 | Common Stock |
| Robert L. Dixon | Director | Sale of securities on an exchange or to another person at price $ 497.14 per share. | 06 Jun 2022 | 420 | 9,491 (0%) | 0% | 497.1 | 208,799 | Common Stock |
| Elizabeth E. Tallett | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 May 2022 | 440 | 9,446 (0%) | 0% | 0 | Common Stock | |
| Lewis Hay | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 May 2022 | 440 | 10,061 (0%) | 0% | 0 | Common Stock | |
| Ryan M. Schneider | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 May 2022 | 440 | 5,154 (0%) | 0% | 0 | Common Stock | |
| R. Kerry Clark | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 May 2022 | 440 | 8,194 (0%) | 0% | 0 | Common Stock | |
| Ramiro G. Peru | Director | Sale of securities on an exchange or to another person at price $ 468.88 per share. | 18 May 2022 | 990 | 9,405 (0%) | 0% | 468.9 | 464,191 | Common Stock |
| Ramiro G. Peru | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 May 2022 | 440 | 10,395 (0%) | 0% | 0 | Common Stock | |
| Robert L. Dixon | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 May 2022 | 440 | 9,911 (0%) | 0% | 0 | Common Stock | |
| Bahija Jallal | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 May 2022 | 440 | 3,342 (0%) | 0% | 0 | Common Stock | |
| Susan Dodson DeVore | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 May 2022 | 440 | 856 (0%) | 0% | 0 | Common Stock | |
| Antonio Fabio Neri | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 May 2022 | 440 | 3,479 (0%) | 0% | 0 | Common Stock | |
| Peter Haytaian | EVP & Pres., DBG & IngenioRx | Sale of securities on an exchange or to another person at price $ 459.75 per share. | 10 Mar 2022 | 4,274 | 23,420 (0%) | 0% | 459.8 | 1,964,972 | Common Stock |
| Peter Haytaian | EVP & Pres., DBG & IngenioRx | Sale of securities on an exchange or to another person at price $ 460.68 per share. | 10 Mar 2022 | 4,105 | 19,315 (0%) | 0% | 460.7 | 1,891,091 | Common Stock |
| Peter Haytaian | EVP & Pres., DBG & IngenioRx | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Mar 2022 | 1,848 | 0 | - | - | Employee Stock Option (Right to Buy) | |
| Peter Haytaian | EVP & Pres., DBG & IngenioRx | Sale of securities on an exchange or to another person at price $ 463.40 per share. | 10 Mar 2022 | 40 | 12,161 (0%) | 0% | 463.4 | 18,536 | Common Stock |
| Peter Haytaian | EVP & Pres., DBG & IngenioRx | Sale of securities on an exchange or to another person at price $ 462.73 per share. | 10 Mar 2022 | 1,240 | 12,201 (0%) | 0% | 462.7 | 573,785 | Common Stock |
| Peter Haytaian | EVP & Pres., DBG & IngenioRx | Sale of securities on an exchange or to another person at price $ 461.72 per share. | 10 Mar 2022 | 5,874 | 13,441 (0%) | 0% | 461.7 | 2,712,143 | Common Stock |
| Peter Haytaian | EVP & Pres., DBG & IngenioRx | Exercise or conversion of derivative security received from the company (such as an option) at price $ 131.80 per share. | 10 Mar 2022 | 1,848 | 29,864 (0%) | 0% | 131.8 | 243,566 | Common Stock |
| Peter Haytaian | EVP & Pres., DBG & IngenioRx | Sale of securities on an exchange or to another person at price $ 458.68 per share. | 10 Mar 2022 | 2,170 | 27,694 (0%) | 0% | 458.7 | 995,336 | Common Stock |
| Blair W. Todt | EVP and Chief Legal Officer | 01 Mar 2022 | 7,508 | 7,508 | - | - | Employee Stock Option (Right to Buy) | ||
| Blair W. Todt | EVP and Chief Legal Officer | 01 Mar 2022 | 191 | 2,534 (0%) | 0% | 451.5 | 86,237 | Common Stock | |
| Blair W. Todt | EVP and Chief Legal Officer | 01 Mar 2022 | 1,883 | 4,417 (0%) | 0% | 0 | Common Stock | ||
| Gail Koziara Boudreaux | Director, President and CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 451.50 per share. | 01 Mar 2022 | 15,352 | 85,786 (0%) | 0% | 451.5 | 6,931,428 | Common Stock |
| Gail Koziara Boudreaux | Director, President and CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 463.49 per share. | 01 Mar 2022 | 1,645 | 120,639 (0%) | 0% | 463.5 | 762,441 | Common Stock |
| Gail Koziara Boudreaux | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2022 | 32,682 | 32,682 | - | - | Employee Stock Option (Right to Buy) | |
| Gail Koziara Boudreaux | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2022 | 8,195 | 93,981 (0%) | 0% | 0 | Common Stock | |
| Gail Koziara Boudreaux | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2022 | 28,303 | 122,284 (0%) | 0% | 0 | Common Stock | |
| John E. Gallina | EVP & Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 463.49 per share. | 01 Mar 2022 | 413 | 57,601 (0%) | 0% | 463.5 | 191,421 | Common Stock |
| John E. Gallina | EVP & Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 451.50 per share. | 01 Mar 2022 | 4,162 | 46,857 (0%) | 0% | 451.5 | 1,879,143 | Common Stock |
| John E. Gallina | EVP & Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2022 | 2,907 | 49,764 (0%) | 0% | 0 | Common Stock | |
| John E. Gallina | EVP & Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2022 | 8,250 | 58,014 (0%) | 0% | 0 | Common Stock | |
| John E. Gallina | EVP & Chief Financial Officer | Gift of securities by or to the insider at price $ 0.00 per share. | 01 Mar 2022 | 1,420 | 56,181 (0%) | 0% | 0 | Common Stock | |
| John E. Gallina | EVP & Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2022 | 11,594 | 11,594 | - | - | Employee Stock Option (Right to Buy) | |
| Gloria M. McCarthy | EVP & Chief Administrative Off | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2022 | 8,832 | 8,832 | - | - | Employee Stock Option (Right to Buy) | |
| Gloria M. McCarthy | EVP & Chief Administrative Off | Payment of exercise price or tax liability using portion of securities received from the company at price $ 451.50 per share. | 01 Mar 2022 | 4,871 | 50,753 (0%) | 0% | 451.5 | 2,199,257 | Common Stock |
| Gloria M. McCarthy | EVP & Chief Administrative Off | Payment of exercise price or tax liability using portion of securities received from the company at price $ 463.49 per share. | 01 Mar 2022 | 487 | 60,731 (0%) | 0% | 463.5 | 225,720 | Common Stock |
| Gloria M. McCarthy | EVP & Chief Administrative Off | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2022 | 8,250 | 61,218 (0%) | 0% | 0 | Common Stock | |
| Gloria M. McCarthy | EVP & Chief Administrative Off | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2022 | 2,215 | 52,968 (0%) | 0% | 0 | Common Stock | |
| Peter Haytaian | EVP & Pres., DBG & IngenioRx | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2022 | 8,832 | 8,832 | - | - | Employee Stock Option (Right to Buy) | |
| Peter Haytaian | EVP & Pres., DBG & IngenioRx | Payment of exercise price or tax liability using portion of securities received from the company at price $ 451.50 per share. | 01 Mar 2022 | 4,667 | 18,044 (0%) | 0% | 451.5 | 2,107,151 | Common Stock |
| Peter Haytaian | EVP & Pres., DBG & IngenioRx | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2022 | 2,215 | 20,259 (0%) | 0% | 0 | Common Stock | |
| Peter Haytaian | EVP & Pres., DBG & IngenioRx | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2022 | 8,250 | 28,509 (0%) | 0% | 0 | Common Stock | |
| Peter Haytaian | EVP & Pres., DBG & IngenioRx | Payment of exercise price or tax liability using portion of securities received from the company at price $ 463.49 per share. | 01 Mar 2022 | 493 | 28,016 (0%) | 0% | 463.5 | 228,501 | Common Stock |
| Ronald W. Penczek | CAO & Controller | Sale of securities on an exchange or to another person at price $ 463.68 per share. | 01 Mar 2022 | 2,423 | 1,902 (0%) | 0% | 463.7 | 1,123,497 | Common Stock |
| Ronald W. Penczek | CAO & Controller | Exercise or conversion of derivative security received from the company (such as an option) at price $ 307.68 per share. | 01 Mar 2022 | 468 | 4,325 (0%) | 0% | 307.7 | 143,994 | Common Stock |
| Ronald W. Penczek | CAO & Controller | Exercise or conversion of derivative security received from the company (such as an option) at price $ 271.27 per share. | 01 Mar 2022 | 653 | 3,857 (0%) | 0% | 271.3 | 177,139 | Common Stock |
| Ronald W. Penczek | CAO & Controller | Exercise or conversion of derivative security received from the company (such as an option) at price $ 311.48 per share. | 01 Mar 2022 | 438 | 3,204 (0%) | 0% | 311.5 | 136,428 | Common Stock |
| Ronald W. Penczek | CAO & Controller | Payment of exercise price or tax liability using portion of securities received from the company at price $ 463.48 per share. | 01 Mar 2022 | 52 | 2,766 (0%) | 0% | 463.5 | 24,101 | Common Stock |
| Ronald W. Penczek | CAO & Controller | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2022 | 953 | 2,818 (0%) | 0% | 0 | Common Stock | |
| Ronald W. Penczek | CAO & Controller | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2022 | 222 | 1,865 (0%) | 0% | 0 | Common Stock | |
| Ronald W. Penczek | CAO & Controller | Payment of exercise price or tax liability using portion of securities received from the company at price $ 451.50 per share. | 01 Mar 2022 | 369 | 1,643 (0%) | 0% | 451.5 | 166,604 | Common Stock |
| Ronald W. Penczek | CAO & Controller | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Mar 2022 | 468 | 0 | - | - | Employee Stock Option (Right to Buy) | |
| Ronald W. Penczek | CAO & Controller | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Mar 2022 | 653 | 654 | - | - | Employee Stock Option (Right to Buy) | |
| Ronald W. Penczek | CAO & Controller | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Mar 2022 | 438 | 877 | - | - | Employee Stock Option (Right to Buy) | |
| Ronald W. Penczek | CAO & Controller | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2022 | 882 | 882 | - | - | Employee Stock Option (Right to Buy) | |
| Felicia F Norwood | EVP & President, GBD | Payment of exercise price or tax liability using portion of securities received from the company at price $ 463.49 per share. | 01 Mar 2022 | 446 | 28,438 (0%) | 0% | 463.5 | 206,717 | Common Stock |
| Felicia F Norwood | EVP & President, GBD | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2022 | 8,832 | 8,832 | - | - | Employee Stock Option (Right to Buy) | |
| Felicia F Norwood | EVP & President, GBD | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2022 | 6,981 | 28,884 (0%) | 0% | 0 | Common Stock | |
| Felicia F Norwood | EVP & President, GBD | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2022 | 2,215 | 21,903 (0%) | 0% | 0 | Common Stock | |
| Felicia F Norwood | EVP & President, GBD | Payment of exercise price or tax liability using portion of securities received from the company at price $ 451.50 per share. | 01 Mar 2022 | 3,568 | 19,688 (0%) | 0% | 451.5 | 1,610,952 | Common Stock |
| Charles Morgan Kendrick | EVP & President, Commercial | Payment of exercise price or tax liability using portion of securities received from the company at price $ 451.50 per share. | 01 Mar 2022 | 804 | 10,670 (0%) | 0% | 451.5 | 363,006 | Common Stock |
| Charles Morgan Kendrick | EVP & President, Commercial | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2022 | 1,938 | 12,608 (0%) | 0% | 0 | Common Stock | |
| Charles Morgan Kendrick | EVP & President, Commercial | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2022 | 2,031 | 14,639 (0%) | 0% | 0 | Common Stock | |
| Charles Morgan Kendrick | EVP & President, Commercial | Payment of exercise price or tax liability using portion of securities received from the company at price $ 463.49 per share. | 01 Mar 2022 | 110 | 14,529 (0%) | 0% | 463.5 | 50,984 | Common Stock |
| Charles Morgan Kendrick | EVP & President, Commercial | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2022 | 7,729 | 7,729 | - | - | Employee Stock Option (Right to Buy) | |
| Ronald W. Penczek | CAO & Controller | Exercise or conversion of derivative security received from the company (such as an option) at price $ 232.04 per share. | 07 Feb 2022 | 818 | 2,830 (0%) | 0% | 232.0 | 189,809 | Common Stock |
| Ronald W. Penczek | CAO & Controller | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 07 Feb 2022 | 653 | 1,307 | - | - | Employee Stock Option (Right to Buy) | |
| Ronald W. Penczek | CAO & Controller | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 07 Feb 2022 | 357 | 0 | - | - | Employee Stock Option (Right to Buy) | |
| Ronald W. Penczek | CAO & Controller | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 07 Feb 2022 | 935 | 468 | - | - | Employee Stock Option (Right to Buy) | |
| Ronald W. Penczek | CAO & Controller | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 07 Feb 2022 | 818 | 0 | - | - | Employee Stock Option (Right to Buy) | |
| Ronald W. Penczek | CAO & Controller | Sale of securities on an exchange or to another person at price $ 453.48 per share. | 07 Feb 2022 | 2,763 | 2,012 (0%) | 0% | 453.5 | 1,252,965 | Common Stock |
| Ronald W. Penczek | CAO & Controller | Exercise or conversion of derivative security received from the company (such as an option) at price $ 271.27 per share. | 07 Feb 2022 | 653 | 4,775 (0%) | 0% | 271.3 | 177,139 | Common Stock |
| Ronald W. Penczek | CAO & Controller | Exercise or conversion of derivative security received from the company (such as an option) at price $ 166.97 per share. | 07 Feb 2022 | 357 | 4,122 (0%) | 0% | 167.0 | 59,608 | Common Stock |
| Ronald W. Penczek | CAO & Controller | Exercise or conversion of derivative security received from the company (such as an option) at price $ 307.68 per share. | 07 Feb 2022 | 935 | 3,765 (0%) | 0% | 307.7 | 287,681 | Common Stock |
| Jeffrey D. Alter | EVP, IngenioRx & Anthem Health | Payment of exercise price or tax liability using portion of securities received from the company at price $ 375.93 per share. | 01 Oct 2021 | 311 | 5,107 (0%) | 0% | 375.9 | 116,914 | Common Stock |
| Prakash R. Patel | EVP & President, DBG | Payment of exercise price or tax liability using portion of securities received from the company at price $ 377.71 per share. | 04 Sep 2021 | 3,507 | 17,230 (0%) | 0% | 377.7 | 1,324,629 | Common Stock |
| Susan Dodson DeVore | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Sep 2021 | 416 | 416 (0%) | 0% | 0 | Common Stock | |
| Ryan M. Schneider | Director | Purchase of securities on an exchange or from another person at price $ 384.36 per share. | 23 Jul 2021 | 1,300 | 4,714 (0%) | 0% | 384.4 | 499,668 | Common Stock |
| Felicia F Norwood | EVP & President, GBD | Payment of exercise price or tax liability using portion of securities received from the company at price $ 387.20 per share. | 02 Jul 2021 | 5,543 | 25,010 (0%) | 0% | 387.2 | 2,146,250 | Common Stock |
| Elizabeth E. Tallett | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 May 2021 | 493 | 9,006 (0%) | 0% | 0 | Common Stock | |
| Lewis Hay | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 May 2021 | 493 | 9,621 (0%) | 0% | 0 | Common Stock | |
| Ryan M. Schneider | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 May 2021 | 493 | 3,414 (0%) | 0% | 0 | Common Stock | |
| R. Kerry Clark | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 May 2021 | 493 | 7,754 (0%) | 0% | 0 | Common Stock | |
| Ramiro G. Peru | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 May 2021 | 493 | 9,955 (0%) | 0% | 0 | Common Stock | |
| Robert L. Dixon | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 May 2021 | 493 | 9,471 (0%) | 0% | 0 | Common Stock | |
| Bahija Jallal | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 May 2021 | 493 | 2,902 (0%) | 0% | 0 | Common Stock | |
| Antonio Fabio Neri | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 May 2021 | 493 | 3,039 (0%) | 0% | 0 | Common Stock | |
| John E. Gallina | EVP & Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 146.93 per share. | 24 May 2021 | 5,775 | 60,095 (0%) | 0% | 146.9 | 848,521 | Common Stock |
| John E. Gallina | EVP & Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 24 May 2021 | 14,761 | 0 | - | - | Employee Stock Option (Right to Buy) | |
| John E. Gallina | EVP & Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 24 May 2021 | 19,908 | 0 | - | - | Employee Stock Option (Right to Buy) | |
| John E. Gallina | EVP & Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 24 May 2021 | 4,038 | 0 | - | - | Employee Stock Option (Right to Buy) | |
| John E. Gallina | EVP & Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 24 May 2021 | 1,962 | 0 | - | - | Employee Stock Option (Right to Buy) | |
| John E. Gallina | EVP & Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 24 May 2021 | 5,775 | 0 | - | - | Employee Stock Option (Right to Buy) | |
| John E. Gallina | EVP & Chief Financial Officer | Gift of securities by or to the insider at price $ 0.00 per share. | 24 May 2021 | 3,301 | 51,019 (0%) | 0% | 0 | Common Stock | |
| John E. Gallina | EVP & Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 397.91 per share. | 24 May 2021 | 4,100 | 54,320 (0%) | 0% | 397.9 | 1,631,431 | Common Stock |
| John E. Gallina | EVP & Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 396.50 per share. | 24 May 2021 | 1,100 | 58,420 (0%) | 0% | 396.5 | 436,150 | Common Stock |
| John E. Gallina | EVP & Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 395.67 per share. | 24 May 2021 | 15,262 | 59,520 (0%) | 0% | 395.7 | 6,038,716 | Common Stock |
| John E. Gallina | EVP & Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 394.62 per share. | 24 May 2021 | 8,163 | 74,782 (0%) | 0% | 394.6 | 3,221,283 | Common Stock |
| John E. Gallina | EVP & Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 393.56 per share. | 24 May 2021 | 17,819 | 82,945 (0%) | 0% | 393.6 | 7,012,846 | Common Stock |
| John E. Gallina | EVP & Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 232.04 per share. | 24 May 2021 | 14,761 | 100,764 (0%) | 0% | 232.0 | 3,425,142 | Common Stock |
| John E. Gallina | EVP & Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 166.97 per share. | 24 May 2021 | 19,908 | 86,003 (0%) | 0% | 167.0 | 3,324,039 | Common Stock |
| John E. Gallina | EVP & Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 132.51 per share. | 24 May 2021 | 4,038 | 66,095 (0%) | 0% | 132.5 | 535,075 | Common Stock |
| John E. Gallina | EVP & Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 131.80 per share. | 24 May 2021 | 1,962 | 62,057 (0%) | 0% | 131.8 | 258,592 | Common Stock |
| Ramiro G. Peru | Director | Sale of securities on an exchange or to another person at price $ 398.02 per share. | 24 May 2021 | 1,308 | 9,462 (0%) | 0% | 398.0 | 520,610 | Common Stock |
| Robert L. Dixon | Director | Sale of securities on an exchange or to another person at price $ 392.87 per share. | 21 May 2021 | 590 | 8,978 (0%) | 0% | 392.9 | 231,793 | Common Stock |
| Julie A. Hill | Director | Sale of securities on an exchange or to another person at price $ 394.00 per share. | 20 May 2021 | 1,308 | 31,213 (0%) | 0% | 394 | 515,352 | Common Stock |
| Peter Haytaian | EVP & President, Commercial | Exercise or conversion of derivative security received from the company (such as an option) at price $ 146.93 per share. | 22 Mar 2021 | 15,593 | 59,544 (0%) | 0% | 146.9 | 2,291,079 | Common Stock |
| Peter Haytaian | EVP & President, Commercial | Exercise or conversion of derivative security received from the company (such as an option) at price $ 131.80 per share. | 22 Mar 2021 | 22,500 | 82,044 (0%) | 0% | 131.8 | 2,965,500 | Common Stock |
| Peter Haytaian | EVP & President, Commercial | Sale of securities on an exchange or to another person at price $ 345.59 per share. | 22 Mar 2021 | 300 | 81,744 (0%) | 0% | 345.6 | 103,677 | Common Stock |
| Peter Haytaian | EVP & President, Commercial | Sale of securities on an exchange or to another person at price $ 347.44 per share. | 22 Mar 2021 | 9,387 | 72,357 (0%) | 0% | 347.4 | 3,261,419 | Common Stock |
| Peter Haytaian | EVP & President, Commercial | Sale of securities on an exchange or to another person at price $ 348.52 per share. | 22 Mar 2021 | 12,416 | 59,941 (0%) | 0% | 348.5 | 4,327,224 | Common Stock |
| Peter Haytaian | EVP & President, Commercial | Sale of securities on an exchange or to another person at price $ 349.53 per share. | 22 Mar 2021 | 26,777 | 33,164 (0%) | 0% | 349.5 | 9,359,365 | Common Stock |
| Peter Haytaian | EVP & President, Commercial | Sale of securities on an exchange or to another person at price $ 350.21 per share. | 22 Mar 2021 | 7,891 | 25,273 (0%) | 0% | 350.2 | 2,763,507 | Common Stock |
| Peter Haytaian | EVP & President, Commercial | Sale of securities on an exchange or to another person at price $ 351.32 per share. | 22 Mar 2021 | 400 | 24,873 (0%) | 0% | 351.3 | 140,528 | Common Stock |
| Peter Haytaian | EVP & President, Commercial | Sale of securities on an exchange or to another person at price $ 352.84 per share. | 22 Mar 2021 | 2,329 | 22,544 (0%) | 0% | 352.8 | 821,764 | Common Stock |
| Peter Haytaian | EVP & President, Commercial | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 22 Mar 2021 | 15,593 | 0 | - | - | Employee Stock Option (Right to Buy) | |
| Peter Haytaian | EVP & President, Commercial | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 22 Mar 2021 | 22,500 | 1,848 | - | - | Employee Stock Option (Right to Buy) | |
| Ronald W. Penczek | SVP, Chief Accounting Officer | Sale of securities on an exchange or to another person at price $ 333.94 per share. | 05 Mar 2021 | 2,068 | 3,137 (0%) | 0% | 333.9 | 690,588 | Common Stock |
| Ronald W. Penczek | SVP, Chief Accounting Officer | Sale of securities on an exchange or to another person at price $ 323.57 per share. | 04 Mar 2021 | 67 | 5,205 (0%) | 0% | 323.6 | 21,679 | Common Stock |
| Blair W. Todt | EVP and Chief Legal Officer | 01 Mar 2021 | 8,238 | 8,238 | - | - | Employee Stock Option (Right to Buy) | ||
| Blair W. Todt | EVP and Chief Legal Officer | 01 Mar 2021 | 2,007 | 2,804 (0%) | 0% | 0 | Common Stock | ||
| Gail Koziara Boudreaux | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2021 | 43,501 | 43,501 | - | - | Employee Stock Option (Right to Buy) | |
| Gail Koziara Boudreaux | Director, President and CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 311.66 per share. | 01 Mar 2021 | 1,644 | 100,300 (0%) | 0% | 311.7 | 512,369 | Common Stock |
| Gail Koziara Boudreaux | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2021 | 73,240 | 101,944 (0%) | 0% | 0 | Common Stock | |
| Gail Koziara Boudreaux | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2021 | 10,595 | 28,704 (0%) | 0% | 0 | Common Stock | |
| Gail Koziara Boudreaux | Director, President and CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 311.48 per share. | 01 Mar 2021 | 35,564 | 18,109 (0%) | 0% | 311.5 | 11,077,475 | Common Stock |
| John E. Gallina | EVP & Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2021 | 23,222 | 54,803 (0%) | 0% | 0 | Common Stock | |
| John E. Gallina | EVP & Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 311.48 per share. | 01 Mar 2021 | 10,633 | 28,571 (0%) | 0% | 311.5 | 3,311,967 | Common Stock |
| John E. Gallina | EVP & Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2021 | 12,357 | 12,357 | - | - | Employee Stock Option (Right to Buy) | |
| John E. Gallina | EVP & Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 311.66 per share. | 01 Mar 2021 | 483 | 54,320 (0%) | 0% | 311.7 | 150,532 | Common Stock |
| John E. Gallina | EVP & Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2021 | 3,010 | 31,581 (0%) | 0% | 0 | Common Stock | |
| Gloria M. McCarthy | EVP & Chief Administrative Off | Payment of exercise price or tax liability using portion of securities received from the company at price $ 311.66 per share. | 01 Mar 2021 | 536 | 55,624 (0%) | 0% | 311.7 | 167,050 | Common Stock |
| Gloria M. McCarthy | EVP & Chief Administrative Off | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2021 | 11,533 | 11,533 | - | - | Employee Stock Option (Right to Buy) | |
| Gloria M. McCarthy | EVP & Chief Administrative Off | Payment of exercise price or tax liability using portion of securities received from the company at price $ 311.48 per share. | 01 Mar 2021 | 11,971 | 30,128 (0%) | 0% | 311.5 | 3,728,727 | Common Stock |
| Gloria M. McCarthy | EVP & Chief Administrative Off | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2021 | 2,810 | 32,938 (0%) | 0% | 0 | Common Stock | |
| Gloria M. McCarthy | EVP & Chief Administrative Off | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2021 | 23,222 | 56,160 (0%) | 0% | 0 | Common Stock | |
| Peter Haytaian | EVP & President, Commercial | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2021 | 11,533 | 11,533 | - | - | Employee Stock Option (Right to Buy) | |
| Peter Haytaian | EVP & President, Commercial | Payment of exercise price or tax liability using portion of securities received from the company at price $ 311.66 per share. | 01 Mar 2021 | 492 | 43,951 (0%) | 0% | 311.7 | 153,337 | Common Stock |
| Peter Haytaian | EVP & President, Commercial | Payment of exercise price or tax liability using portion of securities received from the company at price $ 311.48 per share. | 01 Mar 2021 | 14,231 | 18,411 (0%) | 0% | 311.5 | 4,432,672 | Common Stock |
| Peter Haytaian | EVP & President, Commercial | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2021 | 2,810 | 21,221 (0%) | 0% | 0 | Common Stock | |
| Peter Haytaian | EVP & President, Commercial | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2021 | 23,222 | 44,443 (0%) | 0% | 0 | Common Stock | |
| Ronald W. Penczek | SVP, Chief Accounting Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2021 | 2,573 | 5,314 (0%) | 0% | 0 | Common Stock | |
| Ronald W. Penczek | SVP, Chief Accounting Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2021 | 322 | 2,741 (0%) | 0% | 0 | Common Stock | |
| Ronald W. Penczek | SVP, Chief Accounting Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 311.48 per share. | 01 Mar 2021 | 818 | 2,419 (0%) | 0% | 311.5 | 254,791 | Common Stock |
| Ronald W. Penczek | SVP, Chief Accounting Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 311.67 per share. | 01 Mar 2021 | 42 | 5,272 (0%) | 0% | 311.7 | 13,090 | Common Stock |
| Ronald W. Penczek | SVP, Chief Accounting Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2021 | 1,315 | 1,315 | - | - | Employee Stock Option (Right to Buy) | |
| Leah Stark | EVP & CHRO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 311.48 per share. | 01 Mar 2021 | 158 | 11,794 (0%) | 0% | 311.5 | 49,214 | Common Stock |
| Leah Stark | EVP & CHRO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 311.66 per share. | 01 Mar 2021 | 715 | 12,885 (0%) | 0% | 311.7 | 222,837 | Common Stock |
| Leah Stark | EVP & CHRO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2021 | 7,414 | 7,414 | - | - | Employee Stock Option (Right to Buy) | |
| Leah Stark | EVP & CHRO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2021 | 1,806 | 13,600 (0%) | 0% | 0 | Common Stock | |
| Felicia F Norwood | EVP & President, GBD | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2021 | 11,831 | 30,849 (0%) | 0% | 0 | Common Stock | |
| Felicia F Norwood | EVP & President, GBD | Payment of exercise price or tax liability using portion of securities received from the company at price $ 311.66 per share. | 01 Mar 2021 | 296 | 30,553 (0%) | 0% | 311.7 | 92,251 | Common Stock |
| Felicia F Norwood | EVP & President, GBD | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2021 | 2,810 | 19,018 (0%) | 0% | 0 | Common Stock | |
| Felicia F Norwood | EVP & President, GBD | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2021 | 11,533 | 11,533 | - | - | Employee Stock Option (Right to Buy) | |
| Felicia F Norwood | EVP & President, GBD | Payment of exercise price or tax liability using portion of securities received from the company at price $ 311.48 per share. | 01 Mar 2021 | 220 | 16,208 (0%) | 0% | 311.5 | 68,526 | Common Stock |
| Prakash R. Patel | EVP & President, DBG | Payment of exercise price or tax liability using portion of securities received from the company at price $ 311.66 per share. | 01 Mar 2021 | 551 | 20,737 (0%) | 0% | 311.7 | 171,725 | Common Stock |
| Prakash R. Patel | EVP & President, DBG | Payment of exercise price or tax liability using portion of securities received from the company at price $ 311.48 per share. | 01 Mar 2021 | 186 | 11,422 (0%) | 0% | 311.5 | 57,935 | Common Stock |
| Prakash R. Patel | EVP & President, DBG | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2021 | 2,007 | 13,429 (0%) | 0% | 0 | Common Stock | |
| Prakash R. Patel | EVP & President, DBG | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2021 | 7,859 | 21,288 (0%) | 0% | 0 | Common Stock | |
| Prakash R. Patel | EVP & President, DBG | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2021 | 8,238 | 8,238 | - | - | Employee Stock Option (Right to Buy) | |
| Jeffrey D. Alter | EVP, IngenioRx & Anthem Health | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2021 | 10,876 | 10,876 | - | - | Employee Stock Option (Right to Buy) | |
| Jeffrey D. Alter | EVP, IngenioRx & Anthem Health | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2021 | 2,649 | 5,395 (0%) | 0% | 0 | Common Stock | |
| Ryan M. Schneider | Director | Purchase of securities on an exchange or from another person at price $ 296.03 per share. | 04 Feb 2021 | 1,700 | 2,921 (0%) | 0% | 296.0 | 503,251 | Common Stock |
| Peter Haytaian | EVP & President, Commercial | Sale of securities on an exchange or to another person at price $ 312.76 per share. | 15 Dec 2020 | 3,836 | 32,742 (0%) | 0% | 312.8 | 1,199,747 | Common Stock |
| Peter Haytaian | EVP & President, Commercial | Exercise or conversion of derivative security received from the company (such as an option) at price $ 146.93 per share. | 15 Dec 2020 | 5,833 | 38,475 (0%) | 0% | 146.9 | 857,043 | Common Stock |
| Peter Haytaian | EVP & President, Commercial | Sale of securities on an exchange or to another person at price $ 312.01 per share. | 15 Dec 2020 | 1,897 | 36,578 (0%) | 0% | 312.0 | 591,883 | Common Stock |
| Peter Haytaian | EVP & President, Commercial | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Dec 2020 | 5,833 | 15,593 | - | - | Employee Stock Option (Right to Buy) | |
| Peter Haytaian | EVP & President, Commercial | Sale of securities on an exchange or to another person at price $ 313.42 per share. | 15 Dec 2020 | 100 | 32,642 (0%) | 0% | 313.4 | 31,342 | Common Stock |
| John E. Gallina | EVP & Chief Financial Officer | Gift of securities by or to the insider at price $ 0.00 per share. | 08 Dec 2020 | 2,589 | 39,204 (0%) | 0% | 0 | Common Stock | |
| Gail Koziara Boudreaux | Director, President and CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 313.90 per share. | 01 Dec 2020 | 14,764 | 53,594 (0%) | 0% | 313.9 | 4,634,420 | Common Stock |
| Peter Haytaian | EVP & President, Commercial | Sale of securities on an exchange or to another person at price $ 332.86 per share. | 16 Nov 2020 | 1,056 | 36,010 (0%) | 0% | 332.9 | 351,500 | Common Stock |
| Peter Haytaian | EVP & President, Commercial | Sale of securities on an exchange or to another person at price $ 331.92 per share. | 16 Nov 2020 | 400 | 37,066 (0%) | 0% | 331.9 | 132,768 | Common Stock |
| Peter Haytaian | EVP & President, Commercial | Sale of securities on an exchange or to another person at price $ 330.77 per share. | 16 Nov 2020 | 1,010 | 37,466 (0%) | 0% | 330.8 | 334,078 | Common Stock |
| Peter Haytaian | EVP & President, Commercial | Exercise or conversion of derivative security received from the company (such as an option) at price $ 146.93 per share. | 16 Nov 2020 | 927 | 38,476 (0%) | 0% | 146.9 | 136,204 | Common Stock |
| Peter Haytaian | EVP & President, Commercial | Exercise or conversion of derivative security received from the company (such as an option) at price $ 100.77 per share. | 16 Nov 2020 | 781 | 37,549 (0%) | 0% | 100.8 | 78,701 | Common Stock |
| Peter Haytaian | EVP & President, Commercial | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 16 Nov 2020 | 927 | 21,426 | - | - | Employee Stock Option (Right to Buy) | |
| Peter Haytaian | EVP & President, Commercial | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 16 Nov 2020 | 781 | 0 | - | - | Employee Stock Option (Right to Buy) | |
| Peter Haytaian | EVP & President, Commercial | Sale of securities on an exchange or to another person at price $ 337.00 per share. | 16 Nov 2020 | 300 | 32,642 (0%) | 0% | 337 | 101,100 | Common Stock |
| Peter Haytaian | EVP & President, Commercial | Sale of securities on an exchange or to another person at price $ 335.92 per share. | 16 Nov 2020 | 675 | 32,942 (0%) | 0% | 335.9 | 226,746 | Common Stock |
| Peter Haytaian | EVP & President, Commercial | Sale of securities on an exchange or to another person at price $ 334.87 per share. | 16 Nov 2020 | 1,193 | 33,617 (0%) | 0% | 334.9 | 399,500 | Common Stock |
| Peter Haytaian | EVP & President, Commercial | Sale of securities on an exchange or to another person at price $ 333.97 per share. | 16 Nov 2020 | 1,200 | 34,810 (0%) | 0% | 334.0 | 400,764 | Common Stock |
| Ronald W. Penczek | SVP, Chief Accounting Officer | Sale of securities on an exchange or to another person at price $ 330.75 per share. | 09 Nov 2020 | 1,199 | 3,229 (0%) | 0% | 330.7 | 396,569 | Common Stock |
| Thomas C. Zielinski | EVP & General Counsel | Sale of securities on an exchange or to another person at price $ 292.50 per share. | 03 Nov 2020 | 2 | 20,410 (0%) | 0% | 292.5 | 585 | Common Stock |
| Thomas C. Zielinski | EVP & General Counsel | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Nov 2020 | 1,893 | 1,893 | - | - | Employee Stock Option (Right to Buy) | |
| Thomas C. Zielinski | EVP & General Counsel | Sale of securities on an exchange or to another person at price $ 292.32 per share. | 03 Nov 2020 | 1,893 | 17,910 (0%) | 0% | 292.3 | 553,362 | Common Stock |
| Thomas C. Zielinski | EVP & General Counsel | Exercise or conversion of derivative security received from the company (such as an option) at price $ 232.04 per share. | 03 Nov 2020 | 1,893 | 19,803 (0%) | 0% | 232.0 | 439,252 | Common Stock |
| Thomas C. Zielinski | EVP & General Counsel | Sale of securities on an exchange or to another person at price $ 292.35 per share. | 03 Nov 2020 | 2,500 | 17,910 (0%) | 0% | 292.4 | 730,875 | Common Stock |
| Thomas C. Zielinski | EVP & General Counsel | Sale of securities on an exchange or to another person at price $ 292.07 per share. | 03 Nov 2020 | 4,780 | 20,412 (0%) | 0% | 292.1 | 1,396,095 | Common Stock |
| Peter Haytaian | EVP & President, Commercial | Sale of securities on an exchange or to another person at price $ 293.98 per share. | 15 Oct 2020 | 147 | 37,935 (0%) | 0% | 294.0 | 43,215 | Common Stock |
| Peter Haytaian | EVP & President, Commercial | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Oct 2020 | 4,667 | 781 | - | - | Employee Stock Option (Right to Buy) | |
| Peter Haytaian | EVP & President, Commercial | Sale of securities on an exchange or to another person at price $ 295.00 per share. | 15 Oct 2020 | 1,167 | 36,768 (0%) | 0% | 295 | 344,265 | Common Stock |
| Peter Haytaian | EVP & President, Commercial | Sale of securities on an exchange or to another person at price $ 293.33 per share. | 15 Oct 2020 | 1,120 | 38,082 (0%) | 0% | 293.3 | 328,530 | Common Stock |
| Peter Haytaian | EVP & President, Commercial | Sale of securities on an exchange or to another person at price $ 292.13 per share. | 15 Oct 2020 | 1,600 | 39,202 (0%) | 0% | 292.1 | 467,408 | Common Stock |
| Peter Haytaian | EVP & President, Commercial | Sale of securities on an exchange or to another person at price $ 290.30 per share. | 15 Oct 2020 | 800 | 40,802 (0%) | 0% | 290.3 | 232,240 | Common Stock |
| Peter Haytaian | EVP & President, Commercial | Sale of securities on an exchange or to another person at price $ 287.58 per share. | 15 Oct 2020 | 1,000 | 41,602 (0%) | 0% | 287.6 | 287,580 | Common Stock |
| Peter Haytaian | EVP & President, Commercial | Exercise or conversion of derivative security received from the company (such as an option) at price $ 100.77 per share. | 15 Oct 2020 | 4,667 | 42,602 (0%) | 0% | 100.8 | 470,294 | Common Stock |
| Peter Haytaian | EVP & President, Commercial | Sale of securities on an exchange or to another person at price $ 295.00 per share. | 09 Oct 2020 | 1,167 | 37,935 (0%) | 0% | 295 | 344,265 | Common Stock |
| Peter Haytaian | EVP & President, Commercial | Exercise or conversion of derivative security received from the company (such as an option) at price $ 89.44 per share. | 02 Oct 2020 | 2,075 | 41,177 (0%) | 0% | 89.4 | 185,588 | Common Stock |
| Peter Haytaian | EVP & President, Commercial | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 02 Oct 2020 | 2,592 | 5,448 | - | - | Employee Stock Option (Right to Buy) | |
| Peter Haytaian | EVP & President, Commercial | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 02 Oct 2020 | 2,075 | 0 | - | - | Employee Stock Option (Right to Buy) | |
| Peter Haytaian | EVP & President, Commercial | Sale of securities on an exchange or to another person at price $ 280.00 per share. | 02 Oct 2020 | 4,667 | 39,102 (0%) | 0% | 280 | 1,306,760 | Common Stock |
| Peter Haytaian | EVP & President, Commercial | Exercise or conversion of derivative security received from the company (such as an option) at price $ 100.77 per share. | 02 Oct 2020 | 2,592 | 43,769 (0%) | 0% | 100.8 | 261,196 | Common Stock |
| Prakash R. Patel | EVP & President, DBG | Payment of exercise price or tax liability using portion of securities received from the company at price $ 276.22 per share. | 04 Sep 2020 | 118 | 12,073 (0%) | 0% | 276.2 | 32,594 | Common Stock |
| Felicia F Norwood | EVP & President, GBD | Payment of exercise price or tax liability using portion of securities received from the company at price $ 267.00 per share. | 02 Jul 2020 | 231 | 18,181 (0%) | 0% | 267 | 61,677 | Common Stock |
| Thomas C. Zielinski | EVP & General Counsel | Sale of securities on an exchange or to another person at price $ 297.70 per share. | 08 Jun 2020 | 6,358 | 25,192 (0%) | 0% | 297.7 | 1,892,777 | Common Stock |
| Ramiro G. Peru | Director | Sale of securities on an exchange or to another person at price $ 300.00 per share. | 08 Jun 2020 | 1,102 | 10,770 (0%) | 0% | 300 | 330,600 | Common Stock |
| Peter Haytaian | EVP & President, Commercial | Exercise or conversion of derivative security received from the company (such as an option) at price $ 100.77 per share. | 08 Jun 2020 | 2,087 | 43,769 (0%) | 0% | 100.8 | 210,307 | Common Stock |
| Peter Haytaian | EVP & President, Commercial | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 08 Jun 2020 | 9,334 | 2,075 | - | - | Employee Stock Option (Right to Buy) | |
| Peter Haytaian | EVP & President, Commercial | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 08 Jun 2020 | 2,087 | 8,040 | - | - | Employee Stock Option (Right to Buy) | |
| Peter Haytaian | EVP & President, Commercial | Sale of securities on an exchange or to another person at price $ 300.00 per share. | 08 Jun 2020 | 14,001 | 39,102 (0%) | 0% | 300 | 4,200,300 | Common Stock |
| Peter Haytaian | EVP & President, Commercial | Exercise or conversion of derivative security received from the company (such as an option) at price $ 89.44 per share. | 08 Jun 2020 | 9,334 | 53,103 (0%) | 0% | 89.4 | 834,833 | Common Stock |
| Ronald W. Penczek | SVP, Chief Accounting Officer | Sale of securities on an exchange or to another person at price $ 297.74 per share. | 08 Jun 2020 | 545 | 4,400 (0%) | 0% | 297.7 | 162,268 | Common Stock |
| Robert L. Dixon | Director | Sale of securities on an exchange or to another person at price $ 284.59 per share. | 27 May 2020 | 1,102 | 9,568 (0%) | 0% | 284.6 | 313,618 | Common Stock |
| Elizabeth E. Tallett | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 May 2020 | 699 | 8,513 (0%) | 0% | 0 | Common Stock | |
| Julie A. Hill | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 May 2020 | 699 | 32,521 (0%) | 0% | 0 | Common Stock | |
| Lewis Hay | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 May 2020 | 699 | 9,128 (0%) | 0% | 0 | Common Stock | |
| Ryan M. Schneider | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 May 2020 | 699 | 1,221 (0%) | 0% | 0 | Common Stock | |
| R. Kerry Clark | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 May 2020 | 699 | 7,261 (0%) | 0% | 0 | Common Stock | |
| Ramiro G. Peru | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 May 2020 | 699 | 11,872 (0%) | 0% | 0 | Common Stock | |
| Robert L. Dixon | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 May 2020 | 699 | 10,670 (0%) | 0% | 0 | Common Stock | |
| Bahija Jallal | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 May 2020 | 699 | 2,409 (0%) | 0% | 0 | Common Stock | |
| Antonio Fabio Neri | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 May 2020 | 699 | 2,546 (0%) | 0% | 0 | Common Stock | |
| Julie A. Hill | Director | Sale of securities on an exchange or to another person at price $ 283.26 per share. | 19 May 2020 | 1,102 | 31,822 (0%) | 0% | 283.3 | 312,153 | Common Stock |
| Gloria M. McCarthy | EVP & Chief Administrative Off | Sale of securities on an exchange or to another person at price $ 277.02 per share. | 15 May 2020 | 5,983 | 45,218 (0%) | 0% | 277.0 | 1,657,411 | Common Stock |
| Gloria M. McCarthy | EVP & Chief Administrative Off | Sale of securities on an exchange or to another person at price $ 276.11 per share. | 15 May 2020 | 5,013 | 51,201 (0%) | 0% | 276.1 | 1,384,139 | Common Stock |
| Gloria M. McCarthy | EVP & Chief Administrative Off | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 May 2020 | 18,261 | 0 | - | - | Employee Stock Option (Right to Buy) | |
| Gloria M. McCarthy | EVP & Chief Administrative Off | Sale of securities on an exchange or to another person at price $ 279.18 per share. | 15 May 2020 | 763 | 42,099 (0%) | 0% | 279.2 | 213,014 | Common Stock |
| Gloria M. McCarthy | EVP & Chief Administrative Off | Sale of securities on an exchange or to another person at price $ 278.22 per share. | 15 May 2020 | 2,356 | 42,862 (0%) | 0% | 278.2 | 655,486 | Common Stock |
| Gloria M. McCarthy | EVP & Chief Administrative Off | Sale of securities on an exchange or to another person at price $ 275.00 per share. | 15 May 2020 | 1,600 | 56,214 (0%) | 0% | 275 | 440,000 | Common Stock |
| Gloria M. McCarthy | EVP & Chief Administrative Off | Sale of securities on an exchange or to another person at price $ 273.31 per share. | 15 May 2020 | 100 | 57,814 (0%) | 0% | 273.3 | 27,331 | Common Stock |
| Gloria M. McCarthy | EVP & Chief Administrative Off | Sale of securities on an exchange or to another person at price $ 272.91 per share. | 15 May 2020 | 845 | 57,914 (0%) | 0% | 272.9 | 230,609 | Common Stock |
| Gloria M. McCarthy | EVP & Chief Administrative Off | Sale of securities on an exchange or to another person at price $ 271.09 per share. | 15 May 2020 | 1,601 | 58,759 (0%) | 0% | 271.1 | 434,015 | Common Stock |
| Gloria M. McCarthy | EVP & Chief Administrative Off | Exercise or conversion of derivative security received from the company (such as an option) at price $ 131.80 per share. | 15 May 2020 | 18,261 | 60,360 (0%) | 0% | 131.8 | 2,406,800 | Common Stock |
| Thomas C. Zielinski | EVP & General Counsel | Exercise or conversion of derivative security received from the company (such as an option) at price $ 232.04 per share. | 30 Apr 2020 | 1,892 | 48,303 (0%) | 0% | 232.0 | 439,020 | Common Stock |
| Thomas C. Zielinski | EVP & General Counsel | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 30 Apr 2020 | 2,553 | 0 | - | - | Employee Stock Option (Right to Buy) | |
| Thomas C. Zielinski | EVP & General Counsel | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 30 Apr 2020 | 1,892 | 3,786 | - | - | Employee Stock Option (Right to Buy) | |
| Thomas C. Zielinski | EVP & General Counsel | Sale of securities on an exchange or to another person at price $ 278.17 per share. | 30 Apr 2020 | 14,861 | 31,550 (0%) | 0% | 278.2 | 4,133,884 | Common Stock |
| Thomas C. Zielinski | EVP & General Counsel | Sale of securities on an exchange or to another person at price $ 278.90 per share. | 30 Apr 2020 | 4,445 | 46,411 (0%) | 0% | 278.9 | 1,239,711 | Common Stock |
| Thomas C. Zielinski | EVP & General Counsel | Exercise or conversion of derivative security received from the company (such as an option) at price $ 166.97 per share. | 30 Apr 2020 | 2,553 | 50,856 (0%) | 0% | 167.0 | 426,274 | Common Stock |
| Gloria M. McCarthy | EVP & Chief Administrative Off | Sale of securities on an exchange or to another person at price $ 270.00 per share. | 16 Apr 2020 | 16,884 | 42,099 (0%) | 0% | 270 | 4,558,680 | Common Stock |
| Gloria M. McCarthy | EVP & Chief Administrative Off | Payment of exercise price or tax liability using portion of securities received from the company at price $ 203.30 per share. | 03 Apr 2020 | 4,415 | 58,983 (0%) | 0% | 203.3 | 897,570 | Common Stock |
| Gail Koziara Boudreaux | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Mar 2020 | 33,102 | 68,277 (0%) | 0% | 0 | Common Stock | |
| Gail Koziara Boudreaux | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Mar 2020 | 58,809 | 58,809 | - | - | Employee Stock Option (Right to Buy) | |
| Gail Koziara Boudreaux | Director, President and CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 271.27 per share. | 02 Mar 2020 | 2,440 | 24,115 (0%) | 0% | 271.3 | 661,899 | Common Stock |
| Gail Koziara Boudreaux | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Mar 2020 | 11,060 | 35,175 (0%) | 0% | 0 | Common Stock | |
| John E. Gallina | EVP & Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 271.27 per share. | 02 Mar 2020 | 17,374 | 1,377 (0%) | 0% | 271.3 | 4,713,045 | Common Stock |
| John E. Gallina | EVP & Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Mar 2020 | 37,420 | 41,793 (0%) | 0% | 0 | Common Stock | |
| John E. Gallina | EVP & Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Mar 2020 | 15,926 | 15,926 | - | - | Employee Stock Option (Right to Buy) | |
| John E. Gallina | EVP & Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Mar 2020 | 2,996 | 4,373 (0%) | 0% | 0 | Common Stock | |
| Thomas C. Zielinski | EVP & General Counsel | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Mar 2020 | 12,253 | 12,253 | - | - | Employee Stock Option (Right to Buy) | |
| Thomas C. Zielinski | EVP & General Counsel | Payment of exercise price or tax liability using portion of securities received from the company at price $ 271.27 per share. | 02 Mar 2020 | 13,769 | 15,323 (0%) | 0% | 271.3 | 3,735,117 | Common Stock |
| Thomas C. Zielinski | EVP & General Counsel | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Mar 2020 | 2,304 | 17,627 (0%) | 0% | 0 | Common Stock | |
| Thomas C. Zielinski | EVP & General Counsel | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Mar 2020 | 28,784 | 46,411 (0%) | 0% | 0 | Common Stock | |
| Gloria M. McCarthy | EVP & Chief Administrative Off | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Mar 2020 | 15,926 | 15,926 | - | - | Employee Stock Option (Right to Buy) | |
| Gloria M. McCarthy | EVP & Chief Administrative Off | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Mar 2020 | 28,784 | 54,762 (0%) | 0% | 0 | Common Stock | |
| Gloria M. McCarthy | EVP & Chief Administrative Off | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Mar 2020 | 8,636 | 63,398 (0%) | 0% | 0 | Common Stock | |
| Gloria M. McCarthy | EVP & Chief Administrative Off | Payment of exercise price or tax liability using portion of securities received from the company at price $ 271.27 per share. | 02 Mar 2020 | 15,144 | 22,982 (0%) | 0% | 271.3 | 4,108,113 | Common Stock |
| Gloria M. McCarthy | EVP & Chief Administrative Off | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Mar 2020 | 2,996 | 25,978 (0%) | 0% | 0 | Common Stock | |
| Peter Haytaian | EVP & President, Commercial | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Mar 2020 | 15,926 | 15,926 | - | - | Employee Stock Option (Right to Buy) | |
| Peter Haytaian | EVP & President, Commercial | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Mar 2020 | 37,420 | 41,682 (0%) | 0% | 0 | Common Stock | |
| Peter Haytaian | EVP & President, Commercial | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Mar 2020 | 2,996 | 4,262 (0%) | 0% | 0 | Common Stock | |
| Peter Haytaian | EVP & President, Commercial | Payment of exercise price or tax liability using portion of securities received from the company at price $ 271.27 per share. | 02 Mar 2020 | 19,683 | 1,266 (0%) | 0% | 271.3 | 5,339,407 | Common Stock |
| Ronald W. Penczek | SVP, Chief Accounting Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 271.27 per share. | 02 Mar 2020 | 1,424 | 527 (0%) | 0% | 271.3 | 386,288 | Common Stock |
| Ronald W. Penczek | SVP, Chief Accounting Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Mar 2020 | 369 | 896 (0%) | 0% | 0 | Common Stock | |
| Ronald W. Penczek | SVP, Chief Accounting Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Mar 2020 | 4,030 | 4,926 (0%) | 0% | 0 | Common Stock | |
| Ronald W. Penczek | SVP, Chief Accounting Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Mar 2020 | 1,960 | 1,960 | - | - | Employee Stock Option (Right to Buy) | |
| Leah Stark | EVP & CHRO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Mar 2020 | 9,800 | 9,800 | - | - | Employee Stock Option (Right to Buy) | |
| Leah Stark | EVP & CHRO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Mar 2020 | 7,374 | 12,197 (0%) | 0% | 0 | Common Stock | |
| Leah Stark | EVP & CHRO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 271.27 per share. | 02 Mar 2020 | 160 | 4,823 (0%) | 0% | 271.3 | 43,403 | Common Stock |
| Felicia F Norwood | EVP & President, GBD | Payment of exercise price or tax liability using portion of securities received from the company at price $ 271.27 per share. | 02 Mar 2020 | 219 | 15,416 (0%) | 0% | 271.3 | 59,408 | Common Stock |
| Felicia F Norwood | EVP & President, GBD | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Mar 2020 | 15,926 | 15,926 | - | - | Employee Stock Option (Right to Buy) | |
| Felicia F Norwood | EVP & President, GBD | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Mar 2020 | 2,996 | 18,412 (0%) | 0% | 0 | Common Stock | |
| Prakash R. Patel | EVP & President, DBG | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Mar 2020 | 12,253 | 12,253 | - | - | Employee Stock Option (Right to Buy) | |
| Prakash R. Patel | EVP & President, DBG | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Mar 2020 | 5,991 | 12,191 (0%) | 0% | 0 | Common Stock | |
| Prakash R. Patel | EVP & President, DBG | Payment of exercise price or tax liability using portion of securities received from the company at price $ 271.27 per share. | 02 Mar 2020 | 185 | 6,200 (0%) | 0% | 271.3 | 50,185 | Common Stock |
| Gail Koziara Boudreaux | Director, President and CEO | Purchase of securities on an exchange or from another person at price $ 264.22 per share. | 30 Jan 2020 | 2,000 | 26,555 (0%) | 0% | 264.2 | 528,440 | Common Stock |
| Gail Koziara Boudreaux | Director, President and CEO | Purchase of securities on an exchange or from another person at price $ 263.52 per share. | 30 Jan 2020 | 5,600 | 24,555 (0%) | 0% | 263.5 | 1,475,712 | Common Stock |
| Leah Stark | EVP & CHRO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Dec 2019 | 3,276 | 4,983 (0%) | 0% | 0 | Common Stock | |
| Felicia F Norwood | Exec VP & President, GBD | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Dec 2019 | 11,792 | 15,635 (0%) | 0% | 0 | Common Stock | |
| Prakash R. Patel | EVP & President, DBG | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Dec 2019 | 3,276 | 6,385 (0%) | 0% | 0 | Common Stock | |
| Peter Haytaian | EVP & President, Commercial | Sale of securities on an exchange or to another person at price $ 303.82 per share. | 20 Dec 2019 | 4,166 | 20,949 (0%) | 0% | 303.8 | 1,265,714 | Common Stock |
| Peter Haytaian | EVP & President, Commercial | Sale of securities on an exchange or to another person at price $ 303.32 per share. | 20 Dec 2019 | 4,167 | 25,115 (0%) | 0% | 303.3 | 1,263,934 | Common Stock |
| Thomas C. Zielinski | EVP & General Counsel | Exercise or conversion of derivative security received from the company (such as an option) at price $ 166.97 per share. | 04 Dec 2019 | 2,553 | 39,692 (0%) | 0% | 167.0 | 426,274 | Common Stock |
| Thomas C. Zielinski | EVP & General Counsel | Exercise or conversion of derivative security received from the company (such as an option) at price $ 108.35 per share. | 04 Dec 2019 | 3,064 | 35,247 (0%) | 0% | 108.3 | 331,984 | Common Stock |
| Thomas C. Zielinski | EVP & General Counsel | Exercise or conversion of derivative security received from the company (such as an option) at price $ 232.04 per share. | 04 Dec 2019 | 1,892 | 37,139 (0%) | 0% | 232.0 | 439,020 | Common Stock |
| Thomas C. Zielinski | EVP & General Counsel | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 04 Dec 2019 | 2,553 | 2,553 | - | - | Employee Stock Option (Right to Buy) | |
| Thomas C. Zielinski | EVP & General Counsel | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 04 Dec 2019 | 1,892 | 5,678 | - | - | Employee Stock Option (Right to Buy) | |
| Thomas C. Zielinski | EVP & General Counsel | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 04 Dec 2019 | 3,064 | 0 | - | - | Employee Stock Option (Right to Buy) | |
| Thomas C. Zielinski | EVP & General Counsel | Sale of securities on an exchange or to another person at price $ 288.33 per share. | 04 Dec 2019 | 10,600 | 29,092 (0%) | 0% | 288.3 | 3,056,298 | Common Stock |
| Peter Haytaian | EVP & President, Commercial | Sale of securities on an exchange or to another person at price $ 300.00 per share. | 18 Nov 2019 | 12,095 | 29,282 (0%) | 0% | 300 | 3,628,500 | Common Stock |
| Peter Haytaian | EVP & President, Commercial | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 18 Nov 2019 | 3,762 | 0 | - | - | Employee Stock Option (Right to Buy) | |
| Peter Haytaian | EVP & President, Commercial | Exercise or conversion of derivative security received from the company (such as an option) at price $ 61.88 per share. | 18 Nov 2019 | 3,762 | 41,377 (0%) | 0% | 61.9 | 232,793 | Common Stock |
| Ronald W. Penczek | SVP, Chief Accounting Officer | Sale of securities on an exchange or to another person at price $ 282.00 per share. | 12 Nov 2019 | 357 | 1,938 (0%) | 0% | 282 | 100,674 | Common Stock |
| Ronald W. Penczek | SVP, Chief Accounting Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 12 Nov 2019 | 816 | 818 | - | - | Employee Stock Option (Right to Buy) | |
| Ronald W. Penczek | SVP, Chief Accounting Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 12 Nov 2019 | 357 | 357 | - | - | Employee Stock Option (Right to Buy) | |
| Ronald W. Penczek | SVP, Chief Accounting Officer | Sale of securities on an exchange or to another person at price $ 287.00 per share. | 12 Nov 2019 | 816 | 1,938 (0%) | 0% | 287 | 234,192 | Common Stock |
| Ronald W. Penczek | SVP, Chief Accounting Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 232.04 per share. | 12 Nov 2019 | 816 | 2,754 (0%) | 0% | 232.0 | 189,345 | Common Stock |
| Ronald W. Penczek | SVP, Chief Accounting Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 166.97 per share. | 12 Nov 2019 | 357 | 2,295 (0%) | 0% | 167.0 | 59,608 | Common Stock |
| Peter Haytaian | EVP & President, Commercial | Sale of securities on an exchange or to another person at price $ 270.05 per share. | 28 Oct 2019 | 4,873 | 37,615 (0%) | 0% | 270.1 | 1,315,954 | Common Stock |
| Peter Haytaian | EVP & President, Commercial | Sale of securities on an exchange or to another person at price $ 269.08 per share. | 28 Oct 2019 | 4,713 | 42,488 (0%) | 0% | 269.1 | 1,268,174 | Common Stock |
| Gloria M. McCarthy | EVP & Chief Administrative Off | Payment of exercise price or tax liability using portion of securities received from the company at price $ 238.23 per share. | 03 Oct 2019 | 617 | 38,126 (0%) | 0% | 238.2 | 146,988 | Common Stock |
| Ryan M. Schneider | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Oct 2019 | 522 | 522 (0%) | 0% | 0 | Common Stock | |
| Prakash R. Patel | EVP & President, DBG | Payment of exercise price or tax liability using portion of securities received from the company at price $ 254.23 per share. | 04 Sep 2019 | 109 | 3,109 (0%) | 0% | 254.2 | 27,711 | Common Stock |
| Julie A. Hill | Director | Sale of securities on an exchange or to another person at price $ 295.00 per share. | 26 Jul 2019 | 1,656 | 32,924 (0%) | 0% | 295 | 488,520 | Common Stock |
| Robert L. Dixon | Director | Sale of securities on an exchange or to another person at price $ 294.11 per share. | 26 Jul 2019 | 520 | 9,971 (0%) | 0% | 294.1 | 152,937 | Common Stock |
| Felicia F Norwood | Exec VP & President, GBD | Payment of exercise price or tax liability using portion of securities received from the company at price $ 280.66 per share. | 02 Jul 2019 | 176 | 3,843 (0%) | 0% | 280.7 | 49,396 | Common Stock |
| Thomas C. Zielinski | EVP & General Counsel | Exercise or conversion of derivative security received from the company (such as an option) at price $ 131.80 per share. | 11 Jun 2019 | 3,382 | 41,009 (0%) | 0% | 131.8 | 445,748 | Common Stock |
| Thomas C. Zielinski | EVP & General Counsel | Exercise or conversion of derivative security received from the company (such as an option) at price $ 166.97 per share. | 11 Jun 2019 | 2,552 | 37,627 (0%) | 0% | 167.0 | 426,107 | Common Stock |
| Thomas C. Zielinski | EVP & General Counsel | Exercise or conversion of derivative security received from the company (such as an option) at price $ 108.35 per share. | 11 Jun 2019 | 1,000 | 33,183 (0%) | 0% | 108.4 | 108,350 | Common Stock |
| Thomas C. Zielinski | EVP & General Counsel | Exercise or conversion of derivative security received from the company (such as an option) at price $ 232.04 per share. | 11 Jun 2019 | 1,892 | 35,075 (0%) | 0% | 232.0 | 439,020 | Common Stock |
| Thomas C. Zielinski | EVP & General Counsel | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 11 Jun 2019 | 3,382 | 0 | - | - | Employee Stock Option (Right to Buy) | |
| Thomas C. Zielinski | EVP & General Counsel | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 11 Jun 2019 | 2,552 | 5,106 | - | - | Employee Stock Option (Right to Buy) |